Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Colchicine | 1 | 2020 | 730 | 0.50 | Why? |
| Interleukin-1 | 3 | 2021 | 438 | 0.46 | Why? |
| Testosterone | 2 | 2021 | 596 | 0.30 | Why? |
| Respiratory Insufficiency | 2 | 2021 | 7301 | 0.25 | Why? |
| Fever | 1 | 2020 | 7795 | 0.25 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 2 | 2021 | 1165 | 0.22 | Why? |
| Hypertension, Pulmonary | 2 | 2020 | 970 | 0.22 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.22 | Why? |
| Microscopic Angioscopy | 1 | 2020 | 58 | 0.21 | Why? |
| Drug Hypersensitivity Syndrome | 1 | 2021 | 74 | 0.20 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.20 | Why? |
| Myocarditis | 3 | 2020 | 2731 | 0.19 | Why? |
| Nails | 1 | 2020 | 143 | 0.19 | Why? |
| Intra-Abdominal Fat | 1 | 2021 | 227 | 0.18 | Why? |
| Glomerulonephritis, Membranoproliferative | 1 | 2018 | 30 | 0.18 | Why? |
| Erdheim-Chester Disease | 1 | 2018 | 50 | 0.18 | Why? |
| Brain Diseases | 2 | 2020 | 1463 | 0.18 | Why? |
| Interleukin-6 | 3 | 2021 | 7522 | 0.18 | Why? |
| Adiposity | 1 | 2021 | 329 | 0.18 | Why? |
| Capillaries | 1 | 2020 | 257 | 0.18 | Why? |
| Eosinophilia | 1 | 2021 | 292 | 0.17 | Why? |
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2018 | 57 | 0.17 | Why? |
| Italy | 15 | 2021 | 38444 | 0.17 | Why? |
| Acetaminophen | 1 | 2020 | 326 | 0.17 | Why? |
| Cerebral Cortex | 1 | 2020 | 276 | 0.17 | Why? |
| Vena Cava Filters | 1 | 2017 | 89 | 0.16 | Why? |
| Exercise Tolerance | 1 | 2021 | 634 | 0.16 | Why? |
| Pulmonary Edema | 1 | 2020 | 430 | 0.15 | Why? |
| Arrhythmias, Cardiac | 2 | 2020 | 2510 | 0.15 | Why? |
| Meningitis | 1 | 2017 | 163 | 0.15 | Why? |
| Optic Neuritis | 1 | 2017 | 132 | 0.15 | Why? |
| Radiography, Thoracic | 3 | 2021 | 5486 | 0.15 | Why? |
| Complement C3 | 1 | 2018 | 271 | 0.15 | Why? |
| Receptors, Interleukin-6 | 2 | 2020 | 1383 | 0.15 | Why? |
| Venous Thrombosis | 2 | 2021 | 2739 | 0.14 | Why? |
| Internal Medicine | 1 | 2021 | 557 | 0.14 | Why? |
| Prosthesis Implantation | 1 | 2017 | 261 | 0.14 | Why? |
| Foramen Ovale, Patent | 1 | 2017 | 153 | 0.14 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2021 | 9335 | 0.14 | Why? |
| Coronary Disease | 1 | 2020 | 645 | 0.13 | Why? |
| Mediastinal Emphysema | 1 | 2021 | 519 | 0.13 | Why? |
| Takotsubo Cardiomyopathy | 1 | 2020 | 453 | 0.13 | Why? |
| Empathy | 1 | 2020 | 658 | 0.13 | Why? |
| Inflammasomes | 1 | 2020 | 710 | 0.13 | Why? |
| Ventricular Dysfunction, Right | 1 | 2020 | 639 | 0.12 | Why? |
| Hospitalization | 11 | 2021 | 54280 | 0.12 | Why? |
| Pneumothorax | 1 | 2021 | 758 | 0.12 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.12 | Why? |
| Continuous Positive Airway Pressure | 1 | 2021 | 1187 | 0.12 | Why? |
| Coronavirus Infections | 14 | 2020 | 253789 | 0.12 | Why? |
| Vascular Diseases | 1 | 2020 | 846 | 0.11 | Why? |
| Community Health Services | 1 | 2020 | 1000 | 0.11 | Why? |
| Malnutrition | 1 | 2020 | 932 | 0.11 | Why? |
| Hyperglycemia | 1 | 2021 | 1363 | 0.10 | Why? |
| Noninvasive Ventilation | 2 | 2020 | 2329 | 0.10 | Why? |
| Hypogonadism | 2 | 2021 | 196 | 0.10 | Why? |
| Pulmonary Embolism | 2 | 2021 | 4775 | 0.10 | Why? |
| Oxygen Inhalation Therapy | 2 | 2020 | 3629 | 0.10 | Why? |
| Gene Expression | 1 | 2020 | 3332 | 0.10 | Why? |
| Rituximab | 1 | 2017 | 1096 | 0.10 | Why? |
| Cognitive Dysfunction | 1 | 2020 | 1389 | 0.09 | Why? |
| Diabetes Mellitus | 2 | 2021 | 8207 | 0.09 | Why? |
| Prone Position | 1 | 2020 | 1861 | 0.09 | Why? |
| Cohort Studies | 6 | 2021 | 36005 | 0.09 | Why? |
| Thromboembolism | 1 | 2021 | 2101 | 0.09 | Why? |
| Azithromycin | 2 | 2020 | 3943 | 0.09 | Why? |
| Aged | 22 | 2021 | 215776 | 0.09 | Why? |
| Middle Aged | 24 | 2021 | 270681 | 0.09 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.08 | Why? |
| Male | 26 | 2021 | 367725 | 0.08 | Why? |
| Humans | 37 | 2021 | 930598 | 0.08 | Why? |
| Family | 1 | 2020 | 2909 | 0.08 | Why? |
| Tomography, X-Ray Computed | 6 | 2021 | 25144 | 0.07 | Why? |
| Female | 24 | 2021 | 380317 | 0.07 | Why? |
| Burnout, Professional | 1 | 2020 | 2489 | 0.07 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2020 | 2963 | 0.07 | Why? |
| Kidney Failure, Chronic | 1 | 2020 | 3222 | 0.07 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.06 | Why? |
| Coinfection | 2 | 2020 | 6820 | 0.06 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.06 | Why? |
| Pandemics | 17 | 2021 | 389249 | 0.06 | Why? |
| Follow-Up Studies | 4 | 2021 | 17020 | 0.06 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.06 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.06 | Why? |
| Echocardiography | 3 | 2020 | 3661 | 0.06 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.05 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.05 | Why? |
| Betacoronavirus | 13 | 2020 | 204454 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Age Factors | 4 | 2020 | 21039 | 0.05 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.05 | Why? |
| Pericardium | 1 | 2021 | 228 | 0.05 | Why? |
| Infusions, Spinal | 1 | 2017 | 6 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.05 | Why? |
| Meninges | 1 | 2017 | 40 | 0.04 | Why? |
| Gonadal Steroid Hormones | 1 | 2021 | 328 | 0.04 | Why? |
| Septal Occluder Device | 1 | 2017 | 46 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2020 | 6543 | 0.04 | Why? |
| Visual Field Tests | 1 | 2017 | 77 | 0.04 | Why? |
| Atrophy | 1 | 2017 | 192 | 0.04 | Why? |
| Radionuclide Imaging | 1 | 2018 | 184 | 0.04 | Why? |
| Receptors, Interleukin-1 | 1 | 2018 | 161 | 0.04 | Why? |
| Optic Nerve | 1 | 2017 | 123 | 0.04 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.04 | Why? |
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2018 | 88 | 0.04 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.04 | Why? |
| Survival Rate | 2 | 2021 | 9206 | 0.04 | Why? |
| Administration, Intravenous | 1 | 2020 | 1115 | 0.04 | Why? |
| Respiratory Rate | 1 | 2020 | 691 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2021 | 1654 | 0.04 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.04 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.04 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.04 | Why? |
| Predictive Value of Tests | 2 | 2021 | 9537 | 0.04 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.04 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.03 | Why? |
| Neurodegenerative Diseases | 1 | 2020 | 469 | 0.03 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.03 | Why? |
| Pericardial Effusion | 1 | 2018 | 312 | 0.03 | Why? |
| Mortality | 2 | 2021 | 7132 | 0.03 | Why? |
| White Matter | 1 | 2017 | 369 | 0.03 | Why? |
| Electroencephalography | 1 | 2020 | 1242 | 0.03 | Why? |
| Infectious Disease Incubation Period | 1 | 2020 | 1033 | 0.03 | Why? |
| Pericarditis | 1 | 2018 | 417 | 0.03 | Why? |
| Radiography | 1 | 2020 | 1576 | 0.03 | Why? |
| Secondary Prevention | 1 | 2017 | 762 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Magnetic Resonance Imaging | 2 | 2020 | 6551 | 0.03 | Why? |
| Plasma Exchange | 1 | 2018 | 763 | 0.03 | Why? |
| Aftercare | 1 | 2020 | 1637 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Coronary Angiography | 1 | 2020 | 2275 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Tomography, Optical Coherence | 1 | 2017 | 1008 | 0.02 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.02 | Why? |
| Bacteremia | 1 | 2020 | 1372 | 0.02 | Why? |
| Diabetes Complications | 1 | 2021 | 2358 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.02 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Endovascular Procedures | 1 | 2017 | 1302 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Hypoxia | 1 | 2021 | 3626 | 0.02 | Why? |
| Adult | 5 | 2021 | 244371 | 0.02 | Why? |
| Coronary Artery Disease | 1 | 2020 | 2570 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Emergency Service, Hospital | 2 | 2020 | 14232 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.02 | Why? |
| Fear | 1 | 2020 | 3607 | 0.02 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.02 | Why? |
| Lung | 2 | 2021 | 31049 | 0.01 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
| Stress, Psychological | 1 | 2021 | 10231 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
Tresoldi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(179)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(338)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_